Dissemination of a questionnaire to the rare diseases and cancer care professionals for the submission of pre-indication projects. It explains: the interest of sequencing the complete genome in the patient care pathway, the technical constraints, the organisation to be set up and the expected volumes.
Choice of sequence technologies, definition of storage and calculation architecture which will be deployed (shared memory calculator, computing cluster…), software specification (purchase of licences, software compliance) .
In June 2019, information notices and consent forms – in their various forms: rare diseases, cancer; adults, minors, protected persons– were made available to the genomic platforms of the plan to be used during interviews with the first patients. These documents were created as “draft” versions: Obtaining consent in genetics is organised primarily by regulation […]
Dissemination of a questionnaire to the rare disease and cancer care sectors for the submission of pre-indication projects. The interest of complete genome sequencing in the patient care pathway, the technical constraints, the organisation to be set up and the expected volumes are presented.
Poll of the entire training offer of French universities and public sector engineering schools through their web sites, including the training offer of medicine research and training units (UFR). This first objective was to identify the training that we believe to be necessary to deploy the French Plan for Genomic Medicine 2025. Only immediate vocational […]
The first task addressed by the working group was to provide professionals with operational documents in an ethical manner, necessary to start the first sequencing. Indeed, two types of documents must be submitted to patients by the medical specialist before any diagnosis in the framework of the plan: The information notice provides, in written and […]
The “Ethics, regulation and society” working group is led by: the Directorate-General for Health under the aegis of Arnaud de Guerra (DGS), Aviesan, with Anne Cambon-Thomsen, director of research director, CNRS, member of the European Group on Ethics in Science and New Technologies, and Christine Lemaitre, representative of the Ethics Committee, Inserm. This group includes the various […]
ICPerMed was launched at workshops organised by the European Commission. It includes non-profit public and private bodies for funding health research and the setting up of public policies. ICPerMed wants to contribute to the implementation of personalised medicine for the benefit of patients, citizens and society as a whole and to facilitate the coordination of research […]
Nous utilisons les cookies pour améliorer votre navigation sur notre site.
En validant ce message vous acceptez l’utilisation des cookies. Je valideRéglages des cookies
Privacy & Cookies Policy
Aperçu de la confidentialité
Ce site Web utilise des cookies pour améliorer votre expérience pendant que vous naviguez sur le site Web. Parmi ces cookies, les cookies classés comme nécessaires sont stockés sur votre navigateur car ils sont aussi essentiels au fonctionnement des fonctionnalités de base du site. Nous utilisons également des cookies tiers qui nous aident à analyser et à comprendre comment vous utilisez ce site Web. Ces cookies ne seront stockés dans votre navigateur qu'avec votre consentement. Vous avez également la possibilité de désactiver ces cookies. Mais la désactivation de certains de ces cookies peut avoir un effet sur votre expérience de navigation.